Zoledronic acid for the treatment of thalassemia-induced osteonecrosis.
Mahachoklertwattana
Pat
P
Division of Endocrinology and Metabolism, Department of Pediatrics Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. rapmw@mahidol.ac.th
D004164:Diphosphonates / Q000008:administration & dosage* / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000494:pharmacology; D010020:Osteonecrosis / Q000188:drug therapy* / Q000209:etiology; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology; D000077211:Zoledronic Acid; D017086:beta-Thalassemia / Q000150:complications* / Q000188:drug therapy
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid